Edwards Lifesciences (NYSE: EW) today announced results from the PROGRESS Trial, marking a turning point in the management of moderate aortic stenosis (AS).
Paradigm Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing innovative treatments for rare ...
Newswise — As more legal documents are drafted with large language models (LLMs), falsified citations are becoming a problem ...
2d
[Day 21-25] A 4x productivity paradigm shift. However, the AI also made mistakes and broke articles.
Hello, this is Miyata.This is the continuation of an experiment where an ordinary office worker tries to see "how much can be ...
12don MSN
Change the paradigm: Holon Institute of Technology is integrating industry into tech education
Under new President Professor Refael Barkan, HIT enters a new academic year and a new era – one defined by bridging academia ...
This comprehensive guide delves deep into the transformative self-evolution journey of Codex, covering its core technological ...
INOVIO (NASDAQ: INO) leads Nasdaq gainers, up 213.75%, after the FDA granted accelerated approval for VOCERYQ (INO-3107) for ...
When Language Barriers Vanish, the Premises of Information Warfare ChangeRecently, news of information leaks has been flying ...
Syma Iqbal, MD, provides insights pertaining to various types of upper GI cancers, as well as primary characteristics and risk factors for these diseases. Syma Iqbal, MD, provides an overview of the ...
The immune system in lupus patients might be provoked by totally new, abnormal proteins formed by improper splicing of their ...
SBS Program Challenges Academic Success Norm with Vocational Focus Hosted by Moon Se-yoon and Lee Mi-joo, the program ...
Digital intelligence technologies, such as digital twin and AI agents, will reshape the high-quality development of China's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results